Azienda Ospedaliera S. Croce e Carle Cuneo Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00795613
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

AO S CROCE E CARLE DI CUNEO | A.S.O. S.CROCE E CARLE-HEMATOLOGY DEPT. - VIA M. COPPINO 26-12100 CUNEO ITALY

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Head and Neck Neoplasms (Phase 2)

Hodgkin Disease (Phase 2)

Lymphoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 9